Credit score: CC0 Public Area
There could also be a serious change in nationwide drug coverage coming quickly.
The Trump administration is contemplating reclassifying marijuana from a Schedule I to a Schedule III substance. The change in classification was proposed in 2024 underneath the Biden administration, following a suggestion from the U.S. Division of Well being and Human Providers, and was nonetheless underneath evaluation by the Drug Enforcement Administration (DEA) when the brand new administration took workplace in January.
Whereas the change in classification would not legalize marijuana for leisure use, it could take away restrictions which have hindered medical analysis on marijuana, defined Kent Vrana, director of the Penn State Heart for Hashish and Pure Product Prescribed drugs (CCNPP), which research the advantages and harms of hashish and its potential for treating human illness.
Within the following Q&A, Vrana, who can be the Elliott S. Vesell Professor of Pharmacology on the Penn State Faculty of Medication, spoke about how reclassifying marijuana would have an effect on medical analysis and affected person entry to medical marijuana in addition to the promising advantages of medical marijuana.
Q: What is the distinction between a Schedule I and a Schedule III drug?
Vrana: Below the Managed Substances Act of 1970, Schedule I medicine are outlined as any drug that has the potential for abuse and has no medical advantages. This consists of substances like heroin and LSD. Schedule III medicine, then again, even have abuse potential, however they’ve documented medical advantages. This consists of substances like ketamine, anabolic steroids and testosterone.
Q: Why is marijuana being thought-about for reclassification?
Vrana: Marijuana is a kind of hashish the place the compound tetrahydrocannabinol or THC is dominant, which is the principle psychoactive element. It is at the moment categorised as a Schedule I drug. However, whereas there may be abuse potential with marijuana, we all know that it has medicinal advantages, too.
The Meals and Drug Administration (FDA) has accepted 4 medicine which can be derived from cannabinoids—the compounds present in hashish—for nausea, vomiting and urge for food stimulation, notably for sufferers with most cancers and sufferers with HIV/AIDS.
There’s additionally a prescription drug, purified from hashish, for seizure issues in younger folks. These sorts have seizures possibly 100 instances a day and this drug can cut back the variety of seizures and, in a small proportion, abolish the seizures.
Q: One argument for marijuana reclassification is that present federal insurance policies impeded analysis, together with medical analysis. How so?
Vrana: To make use of a Schedule I drug in analysis, I’ve to get approvals from a number of federal businesses just like the FDA and DEA. I can solely get hashish and cannabinoids from a handful of federally accepted sources. In any other case, it places our federal funding in danger. It makes it more durable for us to conduct medical trials that may assist us higher perceive the potential advantages—and harms—of hashish.
The opposite difficulty is that the hashish we research is not the identical as what folks use or that is perhaps bought within the medical marijuana dispensaries. During the last 30 years, the quantity of THC in hashish has been bred to over 30% by weight. That is 10 instances stronger than what it was.
There are additionally some vaping merchandise which can be nearly pure THC. However the hashish I routinely get from accepted sources is 8% or 10% by weight. It is a large distinction.
Q: What are a few of the implications of not with the ability to research these larger efficiency strains?
Vrana: My heart could be very a lot targeted on potential advantages, however harms as nicely. One of many issues that we spend loads of time occupied with and writing about is the truth that these new excessive efficiency and artificial compounds are within the market they usually have potential harms from drug-drug interactions.
For example, the blood thinner Coumadin, or warfarin, is used when you’ve an arrhythmia otherwise you’ve had a stroke. It has a really slim therapeutic index, that means that the quantity that helps you is one degree however, given slightly extra, it turns into poisonous, and folks begin having bleeding issues and bruising.
We have performed a deep dive into the literature, and there are a number of examples of sufferers who have been on Coumadin and their ranges have been nicely regulated. Then, they began utilizing hashish or elevated their use, and impulsively, that they had a bleeding drawback as a result of the hashish interfered with the metabolism of the Coumadin.
We would like to review that type of stuff, however it may take larger concentrations than what I can get by way of the accepted sources.
Q: What are another promising advantages of medical marijuana?
Vrana: There are a selection of very promising areas. Anxiousness is one. Ache is one other space. The hashish plant makes roughly 180 totally different cannabinoids. Among the ones that do not get you excessive appear to be fairly efficient for ache in animal fashions. However each areas have not been rigorously examined in people.
In Europe, their model of the FDA has accepted a fancy hashish extract that accommodates equal quantities of THC and CBD to assist with muscle spasticity the place the muscle groups turn into stiff and may trigger involuntary muscle spasms. However that hasn’t been accepted in america.
Q: What areas of analysis is your heart targeted on?
Vrana: We’re enthusiastic about neuropathic ache, or ache arising from the nervous system, just like the tingling-like ache that may be a facet impact from most cancers remedy. We’re additionally enthusiastic about seeing how the minor cannabinoids—the compounds that do not get you excessive—assist with bone therapeutic and cartilage restore and the ache that comes with that. In each circumstances, we’re conducting extra analysis trials.
We additionally know that CBD is an anti-inflammatory. We have seen that, in a mouse mannequin, cannabinoids might help with inflammatory bowel illness—colitis particularly.
Lastly, we’re learning how these medicine work together with the physique—what receptors they bind to, how they’re metabolized, what are the mechanisms behind their impact—so we are able to higher perceive how they is perhaps used to profit illness and human well being.
Q: Are there different main implications of reclassifying marijuana exterior of analysis?
Vrana: Apart from making it simpler to conduct analysis, rescheduling may additionally make it simpler for sufferers to entry medical marijuana. It may open the door for insurance coverage corporations to cowl it as a result of they at the moment will not cowl Schedule I medicine.
It might even have a serious impression on the expansion of the business. Due to marijuana’s Schedule I standing, the business is a cash-based system. You possibly can’t use bank cards as a result of the federal authorities oversees the banking system.
Companies can also’t write off enterprise bills or get tax deductions. In that method, rescheduling may assist develop the business as an entire.
Offered by
Pennsylvania State College
Quotation:
Q&A: What would reclassifying marijuana imply for medical analysis? (2025, August 27)
retrieved 27 August 2025
from https://medicalxpress.com/information/2025-08-qa-reclassifying-marijuana-medical.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
